August 7, 2007
In an announcement today, the European Commission said it had suspended Roche's license to market its HIV drug Viracept in the European Union. The drug was withdrawn from the market in June after Roche said some batches were contaminated with ethyl mesilate, which can cause tumors. The commission said the latest action is based on the counsel of the European Medicines Agency and member nations.
Agence France Presse
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.